Related Experiment Video
Updated: May 28, 2026

Investigations on Alterations of Hippocampal Circuit Function Following Mild Traumatic Brain Injury
Published on: November 19, 2012
Memory Impairments: Type, Causes, and Molecular Players-Memory Dysfunction Across Neurologic Insults
Saad A Farooqui1, Maryline Santerre1, Natalia Shcherbik2
1FELS Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Viral infections cause memory loss by damaging the hippocampus via shared molecular pathways. Combination therapies targeting these pathways may offer better treatment for virus-associated memory impairment.
Area of Science:
- Neuroscience
- Virology
- Pathology
Background:
- Viral infections affecting the central nervous system can lead to memory impairment beyond acute neuronal damage.
- Several viruses, including HSV-1, HIV, and SARS-CoV-2, impact the brain through distinct routes.
Purpose of the Study:
- To propose a unifying hypothesis for virus-associated memory impairment as a convergent hippocampal syndrome.
- To identify shared molecular pathways driving hippocampal damage across different viral infections.
- To highlight the potential of combination therapies targeting these pathways.
Main Methods:
- Review of mechanisms by which various viruses affect the central nervous system.
- Identification of converging molecular pathways: MAM dysfunction, neuroinflammation, BBB disruption, and impaired CREB-BDNF signaling.
- Analysis of how these pathways compromise specific hippocampal subfields (dentate gyrus, CA3, CA1).
Main Results:
- Viruses converge on four shared molecular pathways that damage hippocampal circuits critical for memory.
- These pathways lead to specific memory deficits, including pattern separation and associative retrieval.
- Current antiviral therapies do not address organelle-level dysfunction, leaving hippocampal injury unaddressed.
Conclusions:
- Virus-associated memory impairment is a convergent hippocampal syndrome driven by shared downstream pathways.
- Combination therapies targeting MAM dysfunction, neuroinflammation, BBB disruption, and CREB-BDNF signaling may be more effective than pathogen-specific treatments.
- Emerging biomarkers and MRI techniques allow for mechanistic stratification and potential intervention before irreversible damage.
Related Concept Videos
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Alzheimer Disease l: Introduction
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression

